Breaking News, Collaborations & Alliances

ScinoPharm, Raffles PharmaTech Ink API Alliance

Will manufacture Celecoxib, a non-steroidal and anti-inflammatory analgesic API

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ScinoPharm Taiwan, Ltd. and Raffles PharmaTech are collaborating to manufacture Celecoxib, a non-steroidal and anti-inflammatory analgesic API. Raffles will be responsible for the R&D and ScinoPharm will be responsible for manufacturing. Following product launch, both companies will share profits. The drug master file (DMF) is expected to be submitted in 2016, with products available in the U.S. by 2018.    “ScinoPharm (Changshu) is among the first batch of API plants built in compli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters